OLMA - Olema Pharmaceuticals GAAP EPS of -$0.48 November, 07 2023 06:05 PM Olema Pharmaceuticals Inc. 2023-11-07 18:05:15 ET Olema Pharmaceuticals press release ( NASDAQ: OLMA ): Q3 GAAP EPS of -$0.48. Cash, cash equivalents and marketable securities position of $276.9 million as of September 30, 2023. For further details see: Olema Pharmaceuticals GAAP EPS of -$0.48